Clinical Trial Update: Study of Antibody Responses After a Dose of Tetravalent Meningococcal Diphtheria Conjugate Vaccine in Children [Phase 2]

View source ↗

Summary

Phase 2 study evaluating antibody responses after a dose of a tetravalent meningococcal diphtheria conjugate vaccine in children; results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningitis
• Meningococcemia

Drugs mentioned

• Tetravalent meningococcal diphtheria conjugate vaccine (Meningococcal conjugate vaccine, tetravalent, diphtheria toxoid conjugate)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Meningitis, Meningococcemia | Phase 2 | Status: COMPLETED | Results posted: 2009-04-24